Use of Lebrikizumab in Treatment‐Refractory Bullous Pemphigoid: Two Reports

International Journal of Dermatology 2026

View at publisher

Authors: Christoph Zeyen, Farzan Solimani, Meslina Almacı, Kamran Ghoreschi, Rose K. C. Moritz, Margitta Worm

DOI: 10.1111/ijd.70317

Cited by: 0

References: 5

Fields of Study & Subjects

Autoimmune Bullous Skin Diseases Skin and Cellular Biology Research Drug-Induced Adverse Reactions

References 5